Liver Transplantation for Hepatocellular Carcinoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference-Reference-Cited by-同舟云学术

Liver Transplantation for Hepatocellular Carcinoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference

Published:2020-06 Issue:6 Volume:104 Page:1136-1142
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Mehta Neil,Bhangui Prashant,Yao Francis Y.,Mazzaferro Vincenzo,Toso Christian,Akamatsu Nobuhisa,Durand Francois,Ijzermans Jan,Polak Wojciech,Zheng Shusen,Roberts John P.,Sapisochin Gonzalo,Hibi Taizo,Kwan Nancy Man,Ghobrial Mark,Soin Avi

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference104 articles.

1. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.;Mazzaferro;N Engl J Med,1996

2. Metroticket 2.0 model for analysis of competing risks of death after liver transplantation for hepatocellular carcinoma.;Mazzaferro;Gastroenterology,2018

3. Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging.;Yao;Am J Transplant,2007

4. Influence of tumor characteristics on the outcome of liver transplantation among patients with liver cirrhosis and hepatocellular carcinoma.;Herrero;Liver Transpl,2001

5. Liver transplantation in patients with hepatocellular carcinoma across milan criteria.;Herrero;Liver Transpl,2008

Cited by 132 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction models for acute kidney injury following liver transplantation: A systematic review and critical appraisal;Intensive and Critical Care Nursing;2025-02

2. Cucurbitacin I exerts its anticancer effects by inducing cell cycle arrest via the KAT2a-ube2C/E2F1 pathway and inhibiting HepG2-induced macrophage M2 polarization;Biochemical and Biophysical Research Communications;2024-12

3. Living Donor Liver Transplantation for Hepatocellular Carcinoma;Journal of Clinical and Experimental Hepatology;2024-11

4. Perioperative outcomes after hepatectomy for hepatocellular carcinoma among patients with cirrhosis, fatty liver disease, and clinically normal livers;Surgical Oncology;2024-10

5. Low CD8+ Density Variation and R1 Surgical Margin as Independent Predictors of Early Post-Resection Recurrence in HCC Patients Meeting Milan Criteria;Current Oncology;2024-09-10